Peptide-assembled nanoparticles targeting tumor cells and tumor microenvironment for cancer therapy
Tumor cells and corrupt stromal cells in the tumor microenvironment usually overexpress cancer-specific markers that are absent or barely detectable in normal cells, providing available targets for inhibiting the occurrence and development of cancers. It is noticeable that therapeutic peptides are e...
Saved in:
Published in: | Frontiers in chemistry Vol. 11; p. 1115495 |
---|---|
Main Authors: | , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
Frontiers Media S.A
24-01-2023
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Tumor cells and corrupt stromal cells in the tumor microenvironment usually overexpress cancer-specific markers that are absent or barely detectable in normal cells, providing available targets for inhibiting the occurrence and development of cancers. It is noticeable that therapeutic peptides are emerging in cancer therapies and playing more and more important roles. Moreover, the peptides can be self-assembled and/or incorporated with polymeric molecules to form nanoparticles
non-covalent bond, which have presented appealing as well as enhanced capacities of recognizing targeted cells, responding to microenvironments, mediating internalization, and achieving therapeutic effects. In this review, we will introduce the peptide-based nanoparticles and their application advances in targeting tumor cells and stromal cells, including suppressive immune cells, fibrosis-related cells, and angiogenic vascular cells, for cancer therapy. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Xiao Xuan Liu, China Pharmaceutical University, China Reviewed by: Ling Zhu, National Center for Nanoscience and Technology (CAS), China This article was submitted to Nanoscience, a section of the journal Frontiers in Chemistry Edited by: Xing Li, Beijing Institute of Life Science (CAS), China Jianfeng Liu, Chinese Academy of Medical Sciences and Peking Union Medical College, China |
ISSN: | 2296-2646 2296-2646 |
DOI: | 10.3389/fchem.2023.1115495 |